Invention Grant
- Patent Title: Naphthyl acetamides as sPLA.sub.2 inhibitors
- Patent Title (中): 萘乙酰胺作为sPLA2抑制剂
-
Application No.: US91077Application Date: 1998-06-09
-
Publication No.: US6160175APublication Date: 2000-12-12
- Inventor: Theodore Goodson, Jr. , Richard W. Harper , David K. Herron
- Applicant: Theodore Goodson, Jr. , Richard W. Harper , David K. Herron
- Applicant Address: IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: IN Indianapolis
- Priority: GBX9602267 19960205
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/165 ; A61P1/00 ; A61P1/18 ; A61P11/00 ; A61P11/02 ; A61P11/06 ; A61P29/00 ; A61P37/00 ; A61P37/08 ; A61P43/00 ; C07C233/11 ; C07C235/34 ; C07C233/00
Abstract:
A class of novel naphthyl acetamide compounds is disclosed together with the use of such compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
Public/Granted literature
- USD408718S Rod bushing Public/Granted day:1999-04-27
Information query
